| 1 |
34783124 | Ginsenoside RG1 augments doxorubicin-induced apoptotic cell death in MDA-MB-231 breast cancer cell lines. | 2022 Jan |
1 |
| 2 |
34868364 | RBM38 is negatively regulated by miR-320b and enhances Adriamycin resistance in breast cancer cells. | 2022 Jan |
1 |
| 3 |
34978808 | Salidroside Promotes Sensitization to Doxorubicin in Human Cancer Cells by Affecting the PI3K/Akt/HIF Signal Pathway and Inhibiting the Expression of Tumor-Resistance-Related Proteins. | 2022 Jan 28 |
2 |
| 4 |
35134463 | SIRT4 Suppresses Doxorubicin-Induced Cardiotoxicity by Regulating the AKT/mTOR/Autophagy Pathway. | 2022 Mar 15 |
3 |
| 5 |
35148234 | Trypsin cleavage of the β1-adrenergic receptor. | 2022 Mar 1 |
1 |
| 6 |
35216449 | Employing CRISPR-Cas9 to Generate CD133 Synthetic Lethal Melanoma Stem Cells. | 2022 Feb 20 |
1 |
| 7 |
35311115 | Targeting the lncRNA DUXAP8/miR-29a/PIK3CA Network Restores Doxorubicin Chemosensitivity via PI3K-AKT-mTOR Signaling and Synergizes With Inotuzumab Ozogamicin in Chemotherapy-Resistant B-Cell Acute Lymphoblastic Leukemia. | 2022 |
6 |
| 8 |
35329936 | CIP2A as a Key Regulator for AKT Phosphorylation Has Partial Impact Determining Clinical Outcome in Breast Cancer. | 2022 Mar 14 |
1 |
| 9 |
35451580 | miR-205 Reverses MDR-1 Mediated Doxorubicin Resistance via PTEN in Human Liver Cancer HepG2 Cells. | 2022 Mar |
3 |
| 10 |
35499687 | Interplay between PI3K/AKT pathway and heart disorders. | 2022 May 2 |
2 |
| 11 |
32562081 | Methylsulfonylmethane sensitizes endometrial cancer cells to doxorubicin. | 2021 Apr |
1 |
| 12 |
33115283 | Combination treatment strategies with a focus on rosiglitazone and adriamycin for insulin resistant liver cancer. | 2021 Mar |
1 |
| 13 |
33116033 | miR-520b Inhibits IGF-1R to Increase Doxorubicin Sensitivity and Promote Cell Apoptosis in Breast Cancer. | 2021 Mar 1 |
1 |
| 14 |
33556394 | β1-adrenergic receptor N-terminal cleavage by ADAM17; the mechanism for redox-dependent downregulation of cardiomyocyte β1-adrenergic receptors. | 2021 May |
2 |
| 15 |
33669867 | Phosphoinositide 3-Kinase (PI3K) Reactive Oxygen Species (ROS)-Activated Prodrug in Combination with Anthracycline Impairs PI3K Signaling, Increases DNA Damage Response and Reduces Breast Cancer Cell Growth. | 2021 Feb 19 |
1 |
| 16 |
33675923 | The APEX1/miRNA-27a-5p axis plays key roles in progression, metastasis and targeted chemotherapy of gastric cancer. | 2021 Apr 15 |
2 |
| 17 |
33721477 | Antitumor effects of helenalin in doxorubicin-resistant leukemia cells are mediated via mitochondrial mediated apoptosis, loss of mitochondrial membrane potential, inhibition of cell migration and invasion and downregulation of PI3-kinase/AKT/m-TOR signalling pathway. | 2021 Jan-Feb |
1 |
| 18 |
33752173 | Exosomal miR-222 from adriamycin-resistant MCF-7 breast cancer cells promote macrophages M2 polarization via PTEN/Akt to induce tumor progression. | 2021 Mar 22 |
1 |
| 19 |
33766750 | Long non-coding RNAs in the doxorubicin resistance of cancer cells. | 2021 Jun 28 |
1 |
| 20 |
33773562 | Curcumin Rescues Doxorubicin Responsiveness via Regulating Aurora a Signaling Network in Breast Cancer Cells. | 2021 Mar 1 |
1 |
| 21 |
33799790 | Tioconazole and Chloroquine Act Synergistically to Combat Doxorubicin-Induced Toxicity via Inactivation of PI3K/AKT/mTOR Signaling Mediated ROS-Dependent Apoptosis and Autophagic Flux Inhibition in MCF-7 Breast Cancer Cells. | 2021 Mar 11 |
2 |
| 22 |
33800264 | Cryptotanshinone Ameliorates Doxorubicin-Induced Cardiotoxicity by Targeting Akt-GSK-3β-mPTP Pathway In Vitro. | 2021 Mar 8 |
1 |
| 23 |
33923922 | Mangiferin Inhibits Apoptosis in Doxorubicin-Induced Vascular Endothelial Cells via the Nrf2 Signaling Pathway. | 2021 Apr 20 |
1 |
| 24 |
33927626 | A New Chalcone Derivative C49 Reverses Doxorubicin Resistance in MCF-7/DOX Cells by Inhibiting P-Glycoprotein Expression. | 2021 |
1 |
| 25 |
33958586 | B7-H3 suppresses doxorubicin-induced senescence-like growth arrest in colorectal cancer through the AKT/TM4SF1/SIRT1 pathway. | 2021 May 6 |
1 |
| 26 |
34108879 | Astragaloside IV Attenuates the Myocardial Injury Caused by Adriamycin by Inhibiting Autophagy. | 2021 |
1 |
| 27 |
34114685 | Silencing of the CrkL gene reverses the doxorubicin resistance of K562/ADR cells through regulating PI3K/Akt/MRP1 signaling. | 2021 Aug |
1 |
| 28 |
34119884 | Urinary exosomes-based Engineered Nanovectors for Homologously Targeted Chemo-Chemodynamic Prostate Cancer Therapy via abrogating EGFR/AKT/NF-kB/IkB signaling. | 2021 Aug |
2 |
| 29 |
34190523 | Co-administration of apigenin with doxorubicin enhances anti-migration and antiproliferative effects via PI3K/PTEN/AKT pathway in prostate cancer cells. | 2021 Jun |
2 |
| 30 |
34207464 | The Enhanced Efficacy of Intracellular Delivery of Doxorubicin/C6-Ceramide Combination Mediated by the F3 Peptide/Nucleolin System Is Supported by the Downregulation of the PI3K/Akt Pathway. | 2021 Jun 18 |
1 |
| 31 |
34357784 | Retraction of: miR-155 Affects Osteosarcoma MG-63 Cell Autophagy Induced by Adriamycin Through Regulating PTEN-I3K/AKT/mTOR Signaling Pathway (doi: 10.1089/cbr.2017.2306). | 2021 Sep |
1 |
| 32 |
34471052 | Apoptosis Inducing Activity of Rhinacanthin-C in Doxorubicin-Resistant Breast Cancer MCF-7 Cells. | 2021 |
1 |
| 33 |
34584450 | TGF-β-Induced TMEPAI Promotes Epithelial-Mesenchymal Transition in Doxorubicin-Treated Triple-Negative Breast Cancer Cells via SMAD3 and PI3K/AKT Pathway Alteration. | 2021 |
2 |
| 34 |
34695518 | Fisetin-induced PTEN expression reverses cellular senescence by inhibiting the mTORC2-Akt Ser473 phosphorylation pathway in vascular smooth muscle cells. | 2021 Dec |
1 |
| 35 |
34750375 | TCP1 increases drug resistance in acute myeloid leukemia by suppressing autophagy via activating AKT/mTOR signaling. | 2021 Nov 8 |
1 |
| 36 |
34830320 | Doxorubicin-Resistant TNBC Cells Exhibit Rapid Growth with Cancer Stem Cell-like Properties and EMT Phenotype, Which Can Be Transferred to Parental Cells through Autocrine Signaling. | 2021 Nov 18 |
1 |
| 37 |
30940294 | VASH2 Promotes Cell Proliferation and Resistance to Doxorubicin in Non-Small Cell Lung Cancer via AKT Signaling. | 2020 Feb 7 |
2 |
| 38 |
31707337 | Magnoflorine improves sensitivity to doxorubicin (DOX) of breast cancer cells via inducing apoptosis and autophagy through AKT/mTOR and p38 signaling pathways. | 2020 Jan |
2 |
| 39 |
31746308 | High Expression of SIRT1 Associates with the Doxorubicin Resistance of Breast Cancer through the Activation of Akt. | 2020 |
2 |
| 40 |
31843629 | Parameritannin A-2 from Urceola huaitingii enhances doxorubicin-induced mitochondria-dependent apoptosis by inhibiting the PI3K/Akt, ERK1/2 and p38 pathways in gastric cancer cells. | 2020 Jan 25 |
4 |
| 41 |
31883395 | Modeling Neoadjuvant chemotherapy resistance in vitro increased NRP-1 and HER2 expression and converted MCF7 breast cancer subtype. | 2020 May |
1 |
| 42 |
31899608 | MicroRNA-221 promotes breast cancer resistance to adriamycin via modulation of PTEN/Akt/mTOR signaling. | 2020 Feb |
2 |
| 43 |
31903460 | Multifunctional hybrid nanoconstructs facilitate intracellular localization of doxorubicin and genistein to enhance apoptotic and anti-angiogenic efficacy in breast adenocarcinoma. | 2020 Mar 7 |
1 |
| 44 |
31960922 | Overexpression of RSK4 reverses doxorubicin resistance in human breast cancer cells via PI3K/AKT signalling pathway. | 2020 Jun 1 |
2 |
| 45 |
32016465 | Low‑intensity ultrasound enhances the antitumor effects of doxorubicin on hepatocellular carcinoma cells through the ROS‑miR‑21‑PTEN axis. | 2020 Mar |
4 |
| 46 |
32064166 | Econazole nitrate reversed the resistance of breast cancer cells to Adriamycin through inhibiting the PI3K/AKT signaling pathway. | 2020 |
2 |
| 47 |
32133289 | Combination of Ruthenium Complex and Doxorubicin Synergistically Inhibits Cancer Cell Growth by Down-Regulating PI3K/AKT Signaling Pathway. | 2020 |
3 |
| 48 |
32184626 | Berberine Reverses Doxorubicin Resistance by Inhibiting Autophagy Through the PTEN/Akt/mTOR Signaling Pathway in Breast Cancer. | 2020 |
1 |
| 49 |
32340377 | Arctigenin Enhances the Cytotoxic Effect of Doxorubicin in MDA-MB-231 Breast Cancer Cells. | 2020 Apr 23 |
1 |
| 50 |
32591592 | The β-adrenergic receptor antagonist propranolol offsets resistance mechanisms to chemotherapeutics in diverse sarcoma subtypes: a pilot study. | 2020 Jun 26 |
1 |